Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors

Description

This randomized clinical trial is evaluating the impact of a positive psychology intervention (PATH) on anxiety symptoms, depression symptoms, and quality of life in survivors of hematopoietic stem cell transplant (HSCT) compared to usual care.

Conditions

Hematopoietic Stem Cell Transplant

Talk to us

Study Overview

On this page

Study Details

Study overview

This randomized clinical trial is evaluating the impact of a positive psychology intervention (PATH) on anxiety symptoms, depression symptoms, and quality of life in survivors of hematopoietic stem cell transplant (HSCT) compared to usual care.

Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors

Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors

Condition
Hematopoietic Stem Cell Transplant
Intervention / Treatment

-

Contacts and Locations

Tampa

Moffitt Cancer Center, Tampa, Florida, United States, 33612

Boston

Dana Farber Cancer Institute, Boston, Massachusetts, United States, 02215

Durham

Duke Cancer Institute, Durham, North Carolina, United States, 27710

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Adult patients (aged 18 years and older) undergoing allogeneic HSCT and are approaching 100-days post-HSCT
  • * Ability to speak, read, and respond to questions in English or Spanish to complete study procedures
  • * Access to a basic telephone
  • * Patients who underwent allogeneic HSCT for benign hematologic conditions
  • * Patients who received outpatient HSCT
  • * Patients with severe psychiatric or cognitive conditions, such as dementia, determined by their transplant oncologist to make them unable to provide informed consent or comply with study procedures

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Brigham and Women's Hospital,

Hermioni Amonoo, MD, MPP, MPH, PRINCIPAL_INVESTIGATOR, Brigham and Women's Hospital

Study Record Dates

2030-04-30